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Abstract 
Objective: To evaluate the impact of intrauterine insemination timing performed 24 or 36 h later following ovulation 
trigger on clinical pregnancy rate during ovulation induction with clomiphene citrate among infertile women was the 
objective of this study.
Methods: The medical records of 280 infertile patients who have underwent ovulation induction by using clomi‑
phene citrate have been evaluated and cycle outcomes of the patients have been investigated specifically based on 
the timing of intrauterine insemination during the treatment cycle.
Results: The clinical pregnancy rate of the study group based on the timing of intrauterine insemination (24 vs. 36 
h following hCG trigger) was found to be similar regardless of infertility type. The cycle day of which hCG trigger has 
been performed was found to be significantly longer for patients who have achieved clinical pregnancy than patients 
who have not got pregnant following the treatment cycle. Dominant follicle diameter has not been found to affect 
clinical pregnancy rate during treatment cycles with clomiphene citrate.
Conclusions: In this study, intrauterine insemination timing did not affect the cycle outcomes whether the pro‑
cedure has been performed 24 or 36 h later following ovulation trigger with exogenous hCG utilization. The longer 
period of treatment cycle during ovulation induction with clomiphene citrate resulted with higher clinical preg‑
nancy rate. Intrauterine insemination can be done successfully at either 24 or 36 h after hCG in clomiphene citrate 
stimulated cycles. This will allow more flexibility and convenience for both physicians and patients, especially during 
weekends.
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Background
Controlled ovarian stimulation (COS) with intrauterine 
insemination (IUI) is a widely used fertility treatment for 
couples to improve pregnancy rates with mild male fac-
tor, unexplained infertility, cervical factor, anovulation, 
minimal and mild endometriosis (Goverde et al. 2000). It 
is simple, relatively less invazive and expensive procedure 
than other forms of assisted reproductive technologies 
(Dodson and Haney 1991).
Many different time intervals have been suggested in 
ovulation induction cycles after hCG injection for the 
management of infertility so there has been uncertainty 
in the correct timing of insemination. In 1970’s Edwards 
and Steptoe showed that ovulation began at 36–38 h after 
an injection of hCG if the follicular development was 
adequate (Edwards and Steptoe 1974). However Yang 
et al. showed that intrauterine insemination can be done 
at any time between 1 and 48 h after hCG injection with-
out affecting significantly pregnancy outcomes. This flex-
ibility in COH-IUI cycles provides more convenience for 
both patients and clinic staff, especially during weekends 
(Yang et al. 2008). According to World Health Organiza-
tion (WHO) analysis, ovulation occurs from 24 to 56  h 
after the onset of the LH surge, with a mean time of 32 h 
(World Health Organization 1980). However the surveil-
lance of sperm in the cervix is up to 80 h after intercourse 
(Gould et  al. 1984). A 2010 systematic review of trials 
that evaluated the effectiveness of different synchroniza-
tion methods in stimulated and natural cycles for IUI in 
subfertile couples concluded the choice should be based 
on hospital facilities, medical staff, convenience for the 
patient, costs and drop-out levels as no method was 
clearly superior to another (Cantineau et al. 2010).
In this study, we aimed to evaluate the impact of IUI tim-
ing on pregnancy rates in clomiphene citrate/IUI cycles.
Methods
The protocol for the research project has been approved 
by the Ethics Committee of Zekai Tahir Burak Women’s 
Health Education and Research Hospital within which the 
work was undertaken and it conforms to the provisions of 
the Declaration of Helsinki (as revised in Tokyo 2004). The 
medical records of 280 infertile patients who have demon-
strated at least one patent fallopian tube on hysterosalpin-
gography and whose partners had normal spermiogram 
analysis results based on World Health Organization 
(WHO) 2010 criteria have been reviewed after excluding 
patients with endometriosis, medical comorbidities and 
hormonal disturbances. All patients have received clomi-
phene citrate treatment (50–150 mg/day orally starting on 
3–5 cycle day of menstruation and lasting on 7–9 cycle 
days of menstruation) for ovulation induction followed by 
one intrauterine insemination procedure performed on 
24 or 36 h after ovulation trigger by exogenous 10,000 IU 
intramuscular urinary hCG injection upon detection of a 
mature follicle with ≥17 mm diameter. Selection of daily 
dose of CC was decided by regarding the lowest effective 
dose which induces at least one dominant follicle dur-
ing ovulation induction. The IUI attempts of the whole 
study group was ≤6 and ≤3 for PCOS and unexplained 
infertile patients respectively due to the ovulation induc-
tion policy of our institution by using oral CC treatment. 
The demographic features, infertility types, dominant fol-
licle number, endometrial thickness on hCG day, hCG 
type (recombinant or urinary derived hCG) timing of 
intrauterine insemination and clinical pregnancy rates 
of the patients have been evaluated. Following the IUI 
procedures, the patients have not received vaginal pro-
gesterone supplementation for luteal support. A clinical 
pregnancy was defined as the presence of a gestational sac 
with accompanying fetal heartbeat by ultrasound at least 
4  weeks after IUI. Statistical analysis was performed by 
using IBM SPSS Statistics Software (17.0, SPSS Inc., Chi-
cago, IL, USA). Kolmogorov–Smirnov test has been used 
for evaluating the normality of the distributions of contin-
uous variables. The parametric results were presented as 
mean ± standard deviation values and normal distributed 
values were compared by using the independent samples 
t test. Comparison of nonparametric data and paramet-
ric data without normal distribution have been made by 
using Mann–Whitney U test. Categorical variables were 
compared with Fisher’s exact or Pearson Chi square tests. 
p values <0.05 were considered statistically significant.
Results
The age, basal (cycle day 3) FSH, mean mature follicle 
number and infertility duration was found as 26.4 ± 4.9, 
6.6 ± 1.6, 1.55 ± 0.6 and 3.3 ± 2.0, respectively. Thirty-
nine percent of the patients (N:110) have been diagnosed 
as polycystic ovary syndrome (PCOS) and 61  % of the 
patients (N:170) have been diagnosed as unexplained 
infertile. Clinical pregnancy rate per cycle was 12.7  % 
for PCOS patients and 11.2  % for unexplained infertile 
patients (p:0.69). The clinical pregnancy rate of the study 
group based on the timing of intrauterine insemination 
(24 vs. 36 h following hCG trigger) was found to be simi-
lar regardless of infertility type (p:0.97). Receiver Oper-
ating Characteristic (ROC) analysis of the mature follicle 
diameter and clinical pregnancy rate was found to be sta-
tistically nonsignificant (ROC AUC:0.48; p:0.79) (Fig. 1). 
The cycle day of which hCG trigger has been performed 
was found to be longer for patients who have achieved 
clinical pregnancy than patients who have not got preg-
nant following the treatment cycle (mean cycle day num-
ber: 14.1  ±  2.9 vs. 13.3  ±  2.5; ROC AUC:0.59; p:0.01) 
(Fig. 2).
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Discussion
Intrauterine insemination with controlled ovarian hyper-
stimulation has been used over the years, as a treatment 
for mild male factor, anovulation and unexplained infer-
tility (Goverde et al. 2000; Guzick et al. 1999). The time of 
administration of intrauterine insemination is the most 
critical factor. Regimens vary between centers and also 
between clinicians. Hence the correct timing of insemi-
nation to improve pregnancy is recently a debated issue.
Pryor et al. showed an improved pregnancy rate when 
IUI was performed with a time interval of 38–40 h (60 % 
pregnancy rate) as compared to shorter IUI interval (0 % 
pregnancy rate) after hCG. However, the small number of 
patients and the different sperm preparation techniques 
used between the two groups were the main limitations 
of the study. While 54 % of patients in the 38–40 h group 
had sperm prepared with a sperm swim-up technique, 
only 13  % of those in the 32–34  h group had this type 
of sperm preparation. Also the males in the Pryor study 
were all with spinal cord injury and had sperm recovered 
via vibratory stimulation. The sperm counts were low and 
the sperm preparation techniques may have been more 
of a deciding factor than was the timing of the IUI and 
may have accounted for the difference in pregnancy rates 
(Pryor et al. 2001).
There are some important factors affecting the outcome 
of COH-IUI. These factors include female age, tube mal-
function, duration of infertility, endometrial thickness, 
number of mature follicles, various techniques of semen 
preparation, sperm motility and concentration (Campana 
et  al. 1996; Duran et  al. 2002; Khalil et  al. 2001; Demir 
et al. 2011; Tomilson et al. 1996). In our study, we found 
no significant difference with respect to these param-
eters affecting the outcome among the groups. Also there 
was no relationship between the average mature follicle 
size and clinical pregnancy outcomes (ROC AUC:0.48; 
p:0.79). In this study, we have demonstrated that the 
longer the treatment cycle with clomiphene citrate, the 
higher the clinical pregnancy rate. This result could have 
been related to the delayed maturity of dominant folli-
cles during clomiphene citrate treatment cycles. Patiently 
waiting for later hCG trigger during ovulation induction 
with CC followed by intrauterine insemination or detec-
tion of spontaneous LH surge on urine LH ovulation 
kit can potentially increase the clinical pregnancy rates 
regardless of the timing of intrauterine insemination.
Robb et  al. (2004) showed no significant difference 
in pregnancy outcomes between IUIs performed at 24 
versus 36  h after hCG with 182 clomiphene citrate/IUI 
cycles in 90 women. However the small numbers, low 
overall pregnancy rates and inclusion of various causes 
Fig. 1 Receiver operating characteristic (ROC) analysis of the mature 
follicle diameter and clinical pregnancy rate
Fig. 2 Receiver operating characteristic (ROC) analysis of delayed 
hCG trigger during ovulation induction treatment and clinical preg‑
nancy rate. Area under curve (AUC) 0.59; 95 % CI 0.51–0.67; p 0.01
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of female infertility diagnosis, including poor ovarian 
reserve, anovulatory, unexplained, anatomic, male factor 
are the possible weaknesses of the retrospective study. In 
our study the patients were divided in two groups. One 
hundred and ten (39  %) patients were polycystic ovary 
and one hundred and seventy (61 %) patients were unex-
plained. To homogenize the study groups, we excluded 
other possible causes of infertility. Clinical pregnancy 
rates per cycle was 12.7  % in PCOS group and 11.2  % 
was in unexplained group (p:0.69). There was also no sig-
nificant difference in pregnancy outcomes whether hCG 
was administered at 24 or 36  h prior to IUI in clomi-
phene citrate stimulated cycles in both groups (p:0.97). 
Our results were consistent with Lewis, Wang and Cla-
man’s (Lewis et al. 2006; Claman et al. 2004). In an other 
study, Ragni et  al. (2004) showed significant increases 
in pregnancy rates when intrauterine insemination was 
performed during the preovulatory and periovulatory 
periods, but not the postovulatory period. In a retro-
spective study, Xu et al. have concluded that the female 
age, infertile duration, ovarian stimulation and follicle 
number, cause of infertility were the main factors affect-
ing clinical pregnancy outcome. In the same study, the 
sperm density, and cycle numbers have been found to 
influence pregnancy outcome too but the insemina-
tion timing, and frequency have been found to exert lit-
tle effect (Xu et  al. 2013). In a prospective randomized 
trial, Rahman et  al. (2010) have evaluated the clinical 
efficacy of double IUI over single IUI and no benefit of 
double IUI has been detected among unexplained infer-
tile patients. Although the best application time and 
frequency for IUI procedures have not been detected, 
longer survival period of spermatozoa within the female 
genital tract, unlike oocyte, result with broader time 
interval preferences for successful IUI procedures. 
Future studies are needed for clarifying the best timing 
for IUI procedures to enhance pregnancy rates following 
ovulation induction.
To conclude, our data showed intrauterine insemina-
tion can be done successfully at either 24 or 36  h after 
hCG in clomiphene citrate stimulated cycles. This will 
allow more flexibility and convenience for both physi-
cians and patients, especially for unnecessary obligation 
to perform IUI procedures on weekends.
Conclusion
In this study, our data showed intrauterine insemination 
timing did not affect the cycle outcomes whether the 
procedure has been performed 24 or 36 h later following 
ovulation trigger with exogenous hCG utilization. The 
longer period of treatment cycle during ovulation induc-
tion with clomiphene citrate resulted with higher clinical 
pregnancy rate. Intrauterine insemination can be done 
successfully at either 24 or 36 h after hCG in clomiphene 
citrate stimulated cycles. This will allow more flexibility 
and convenience for both physicians and patients, espe-
cially during weekends.
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